US · USD
JAZZ
Jazz Pharmaceuticals PLC
- Day's range
- $234.12 – $238.87
- Day's volume
- $198.8M
- 52-week range
- $131.16 – $261.62
Follow JAZZ in the Fuolio
See how JAZZ weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountJAZZ in numbers
- Market cap
- $15.3B
- P/E
- 16.29
- P/B
- 3.19
- Dividend yield (12m)
- 0.00%
JAZZ trades at 16.29 times its earnings of the last 12 months.
JAZZ price history
JAZZ risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +33.71% | +99.64% | +96.91% |
| Volatility (annualized) | 25.49% | 28.24% | 27.07% |
| Largest drawdown | -8.44% | -26.06% | -34.31% |
| Positive months | 7/12 | 21/36 | 33/60 |
How much did investing in JAZZ return?
$1,000.00 invested on 11/01/2021 would be worth $1,969.13 today.
- Value today in JAZZ
- $1,969.13
- Return over the period
- +96.91%
- Return per year
- +14.75%
- In the S&P 500
- $1,702.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
JAZZ fundamentals
Valuation
- P/E16.29
- P/B3.19
- EV/EBITDA—
- EV/EBIT20.13
- EV/Revenue3.92
- P/EBIT17.08
- P/S3.33
- P/OCF9.22
- P/FCF9.63
- Earnings yield4.97%
- PEG ratio—
- Earnings per share$14.49
- Book value per share$73.97
Debt
- Net debt$2.7B
- Net debt/EBITDA—
- Net debt/Equity0.57
- Debt/Equity0.91
- Current ratio1.78
- Quick ratio1.58
- Cash ratio0.73
Efficiency
- Gross margin—
- EBITDA margin—
- Operating margin19.49%
- Net margin20.45%
- Asset turnover0.42
Profitability
- ROE19.59%
- ROA8.49%
- ROIC11.91%
- Payout0.00%
Growth
- Revenue CAGR (5 years)11.87%
- Earnings CAGR (5 years)87.90%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is JAZZ's fair price?
Two classic value formulas, with today's numbers. The current price is $236.04.
- Graham's fair price
- $155.31
- 34.20% below the price
√(22.50 × $14.49 × $73.97)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to JAZZ: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
JAZZ's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -29.38 | 13.35 | 18.49 | -45.03 | -23.86 | 38.96 | 16.01 | 15.82 |
| P/B | 2.42 | 1.83 | 2.05 | 3.27 | 1.98 | 2.54 | 2.69 | 2.56 |
| EV/EBITDA | — | 14.91 | 19.50 | — | 67.64 | 26.04 | 17.07 | 13.27 |
| Earnings per share | -$5.79 | $9.22 | $6.65 | -$3.54 | -$5.34 | $4.24 | $9.32 | $7.84 |
| Book value per share | $70.15 | $67.41 | $59.94 | $48.72 | $64.23 | $64.97 | $55.42 | $48.33 |
| ROE | -8.25% | 13.68% | 11.10% | -7.26% | -8.31% | 6.52% | 16.82% | 16.21% |
| ROIC | -2.94% | 9.20% | 7.28% | -0.47% | 1.81% | 7.07% | 13.05% | 12.90% |
| EBITDA margin | -9.11% | 18.42% | 15.88% | -0.96% | 6.37% | 16.79% | 25.33% | 33.32% |
| Net margin | -8.35% | 13.77% | 10.82% | -6.12% | -10.65% | 10.10% | 24.21% | 23.64% |
| Net debt/EBITDA | — | 4.93 | 6.91 | — | 27.71 | 2.61 | 1.77 | 2.04 |
JAZZ's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $4.3B | $4.1B | $3.8B | $3.7B | $3.1B | $2.4B |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | -$388.6M | $749.4M | $609M | -$35.2M | $197M | $396.8M |
| EBIT | -$430.2M | $716.6M | $578.6M | -$65.5M | $170.3M | $378.1M |
| Financial result | — | — | — | — | — | — |
| Income before tax | -$627.9M | $470.4M | $297.9M | -$372.8M | -$112.8M | $275.1M |
| Income tax | $272.4M | $91.4M | $119.9M | $158.6M | -$216.1M | -$33.5M |
| Net income | -$356.1M | $560.1M | $414.8M | -$224.1M | -$329.7M | $238.6M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does JAZZ pay dividends?
JAZZ has no distributions on record.
About Jazz Pharmaceuticals
- Sector
- Manufacturing
Questions about JAZZ
How much is JAZZ today?
JAZZ is at $236.04 (0.16% on the day), last traded on 10/05/2026.
What are the P/E and P/B of JAZZ?
JAZZ trades at a P/E of 16.29 and a P/B of 3.19.
How much did JAZZ return in 12 months?
JAZZ returned 33.71% in 12 months, with annualized volatility of 25.49% and a largest drawdown of -8.44%.